Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in Week in Review

Week in Review: Osaka Enters $445 Million Deal for Two Hearing Loss Candidates from France's Cilcare
Week in Review: Structure Reports Efficacy of Obesity Drug; Raises $476 Million
Week in Review: Week in Review: MediLink and BioNTech Form $1.8 Billion ADC Partnership
Week in Review: Hengrui and Dearon Announce $7.2 Billion in Drug Licensings
Week in Review: Takeda Options Alzheimer's Therapy from AC Immune in $2.2 Billion Deal
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital